|
1
|
Tack J, Talley NJ, Camilleri M, et al:
Functional gastroduodenal disorders. Gastroenterology.
130:1466–1479. 2006. View Article : Google Scholar
|
|
2
|
Geeraerts B and Tack J: Functional
dyspepsia: past, present, and future. J Gastroenterol. 43:251–255.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tack J and Talley NJ: Gastroduodenal
disorders. Am J Gastroenterol. 105:757–763. 2010. View Article : Google Scholar
|
|
4
|
Kojima M, Hosoda H, Date Y, Nakazato M,
Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing
acylated peptide from stomach. Nature. 402:656–660. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matsumoto M, Kitajima Y, Iwanami T, et al:
Structural similarity of ghrelin derivatives to peptidyl growth
hormone secretagogues. Biochem Biophys Res Commun. 284:655–659.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanaka M, Hayashida Y, Iguchi T, Nakao N,
Nakai N and Nakashima K: Organization of the mouse ghrelin gene and
promoter: occurrence of a short noncoding first exon.
Endocrinology. 142:3697–3700. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hosoda H, Kojima M, Matsuo H and Kangawa
K: Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin
peptide in gastrointestinal tissue. Biochem Biophys Res Commun.
279:909–913. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen CY, Asakawa A, Fujimiya M, Lee SD and
Inui A: Ghrelin gene products and the regulation of food intake and
gut motility. Pharmacol Rev. 61:430–481. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Asakawa A, Inui A, Kaga T, et al: Ghrelin
is an appetite-stimulatory signal from stomach with structural
resemblance to motilin. Gastroenterology. 120:337–345. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakazato M, Murakami N, Date Y, et al: A
role for ghrelin in the central regulation of feeding. Nature.
409:194–198. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wren AM, Small CJ, Ward HL, et al: The
novel hypothalamic peptide ghrelin stimulates food intake and
growth hormone secretion. Endocrinology. 141:4325–4328. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Inui A: Ghrelin: an orexigenic and
somatotrophic signal from the stomach. Nat Rev Neurosci. 2:551–560.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
An W, Li Y, Xu G, et al: Modulation of
ghrelin O-acyltransferase expression in pancreatic islets.
Cell Physiol Biochem. 26:707–716. 2010.
|
|
14
|
Murray CD, Martin NM, Patterson M, et al:
Ghrelin enhances gastric emptying in diabetic gastroparesis: a
double blind, placebo controlled, crossover study. Gut.
54:1693–1698. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tack J, Depoortere I, Bisschops R, Verbeke
K, Janssens J and Peeters T: Influence of ghrelin on gastric
emptying and meal-related symptoms in idiopathic gastroparesis.
Aliment Pharmacol Ther. 22:847–853. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tack J, Depoortere I, Bisschops R, et al:
Influence of ghrelin on interdigestive gastrointestinal motility in
humans. Gut. 55:327–333. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mori M, Suzuki H, Masaoka T, et al:
Intravenous ghrelin administration enhances gastric acid secretion
- evaluation using wireless pH capsule. Aliment Pharmacol Ther.
24:96–103. 2006. View Article : Google Scholar
|
|
18
|
Masuda Y, Tanaka T, Inomata N, et al:
Ghrelin stimulates gastric acid secretion and motility in rats.
Biochem Biophys Res Commun. 276:905–908. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Castaneda TR, Tong J, Datta R, Culler M
and Tschop MH: Ghrelin in the regulation of body weight and
metabolism. Front Neuroendocrinol. 31:44–60. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fetissov SO, Laviano A, Kalra S and Inui
A: Update on ghrelin. Int J Pept. 2010:9635012010. View Article : Google Scholar
|
|
21
|
Asakawa A, Inui A, Kaga T, et al: A role
of ghrelin in neuroendocrine and behavioral responses to stress in
mice. Neuroendocrinology. 74:143–147. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hotta M, Ohwada R, Akamizu T, Shibasaki T,
Takano K and Kangawa K: Ghrelin increases hunger and food intake in
patients with restricting-type anorexia nervosa: a pilot study.
Endocr J. 56:1119–1128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Akamizu T, Iwakura H, Ariyasu H, et al:
Effects of ghrelin treatment on patients undergoing total hip
replacement for osteoarthritis: different outcomes from studies in
patients with cardiac and pulmonary cachexia. J Am Geriatr Soc.
56:2363–2365. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miki K, Maekura R, Nagaya N, et al:
Ghrelin treatment of cachectic patients with chronic obstructive
pulmonary disease: a multicenter, randomized, double-blind,
placebo-controlled trial. PloS One. 7:e357082012. View Article : Google Scholar
|
|
25
|
Akamizu T, Iwakura H, Ariyasu H, et al:
Repeated administration of ghrelin to patients with functional
dyspepsia: its effects on food intake and appetite. Eur J
Endocrinol. 158:491–498. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wo JM, Ejskjaer N, Hellstrom PM, et al:
Randomised clinical trial: ghrelin agonist TZP-101 relieves
gastroparesis associated with severe nausea and vomiting -
randomised clinical study subset data. Aliment Pharmacol Ther.
33:679–688. 2011. View Article : Google Scholar
|
|
27
|
Drossman DA and Dumitrascu DL: Rome III:
New standard for functional gastrointestinal disorders. J
Gastrointestin Liver Dis. 15:237–241. 2006.PubMed/NCBI
|
|
28
|
Miwa H: Why dyspepsia can occur without
organic disease: pathogenesis and management of functional
dyspepsia. J Gastroenterol. 47:862–871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miwa H: Life style in persons with
functional gastrointestinal disorders - large-scale internet survey
of lifestyle in Japan. Neurogastroenterol Motil. 24:464–471.
e2172012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Norton GR, Norton PJ, Asmundson GJ,
Thompson LA and Larsen DK: Neurotic butterflies in my stomach: the
role of anxiety, anxiety sensitivity and depression in functional
gastrointestinal disorders. J Psychosom Res. 47:233–240. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khoo J, Rayner CK, Feinle-Bisset C, Jones
KL and Horowitz M: Gastrointestinal hormonal dysfunction in
gastroparesis and functional dyspepsia. Neurogastroenterol Motil.
22:1270–1278. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Quartero AO, de Wit NJ, Lodder AC, Numans
ME, Smout AJ and Hoes AW: Disturbed solid-phase gastric emptying in
functional dyspepsia: a meta-analysis. Dig Dis Sci. 43:2028–2033.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Geeraerts B, Van Oudenhove L, Fischler B,
et al: Influence of abuse history on gastric sensorimotor function
in functional dyspepsia. Neurogastroenterol Motil. 21:33–41. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Holtmann G, Siffert W, Haag S, et al:
G-protein beta 3 subunit 825 CC genotype is associated with
unexplained (functional) dyspepsia. Gastroenterology. 126:971–979.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Toyoshima F, Oshima T, Nakajima S, et al:
Serotonin transporter gene polymorphism may be associated with
functional dyspepsia in a Japanese population. BMC Med Genet.
12:882011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mearin F, Perez-Oliveras M, Perello A, et
al: Dyspepsia and irritable bowel syndrome after a Salmonella
gastroenteritis outbreak: one-year follow-up cohort study.
Gastroenterology. 129:98–104. 2005.PubMed/NCBI
|
|
37
|
Drossman DA: The functional
gastrointestinal disorders and the Rome III process.
Gastroenterology. 130:1377–1390. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Danesh J, Lawrence M, Murphy M, Roberts S
and Collins R: Systematic review of the epidemiological evidence on
Helicobacter pylori infection and nonulcer or uninvestigated
dyspepsia. Arch Intern Med. 160:1192–1198. 2000.PubMed/NCBI
|
|
39
|
Kawamura A, Adachi K, Takashima T, et al:
Prevalence of functional dyspepsia and its relationship with
Helicobacter pylori infection in a Japanese population. J
Gastroenterol Hepatol. 16:384–388. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Thumshirn M, Camilleri M, Saslow SB,
Williams DE, Burton DD and Hanson RB: Gastric accommodation in
non-ulcer dyspepsia and the roles of Helicobacter pylori
infection and vagal function. Gut. 44:55–64. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sarnelli G, Cuomo R, Janssens J and Tack
J: Symptom patterns and pathophysiological mechanisms in dyspeptic
patients with and without Helicobacter pylori. Dig Dis Sci.
48:2229–2236. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Savarino E, Zentilin P, Dulbecco P,
Malesci A and Savarino V: The role of Acid in functional dyspepsia.
Am J Gastroenterol. 106:1168–1169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jin X and Li YM: Systematic review and
meta-analysis from Chinese literature: the association between
Helicobacter pylori eradication and improvement of
functional dyspepsia. Helicobacter. 12:541–546. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Moayyedi P, Soo S, Deeks J, et al:
Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Cochrane Database Syst Rev. 2006:CD0020962006.PubMed/NCBI
|
|
45
|
Moayyedi P: Helicobacter pylori
eradication for functional dyspepsia: what are we treating?:
comment on ‘Helicobacter pylori eradication in functional
dyspepsia’. Arch Intern Med. 171:1936–1937. 2011. View Article : Google Scholar
|
|
46
|
Suzuki H and Moayyedi P: Helicobacter
pylori infection in functional dyspepsia. Nat Rev Gastroenterol
Hepatol. 10:168–174. 2013. View Article : Google Scholar
|
|
47
|
Sugano K: Should we still subcategorize
Helicobacter pylori-associated dyspepsia as functional
disease? J Neurogastroenterol Motil. 17:366–371. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tack J, Caenepeel P, Fischler B,
Piessevaux H and Janssens J: Symptoms associated with
hypersensitivity to gastric distention in functional dyspepsia.
Gastroenterology. 121:526–535. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Boeckxstaens GE, Rumessen JJ, de Wit L,
Tytgat GN and Vanderwinden JM: Abnormal distribution of the
interstitial cells of cajal in an adult patient with
pseudo-obstruction and megaduodenum. Am J Gastroenterol.
97:2120–2126. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rhee PL, Kim YH, Son HJ, et al: Evaluation
of individual symptoms cannot predict presence of gastric
hypersensitivity in functional dyspepsia. Dig Dis Sci.
45:1680–1684. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chrousos GP: Regulation and dysregulation
of the hypothalamic-pituitary-adrenal axis. The
corticotropin-releasing hormone perspective. Endocrinol Metab Clin
North Am. 21:833–858. 1992.PubMed/NCBI
|
|
52
|
Lamberts SW, Verleun T, Oosterom R, de
Jong F and Hackeng WH: Corticotropin-releasing factor (ovine) and
vasopressin exert a synergistic effect on adrenocorticotropin
release in man. J Clin Endocrinol Metab. 58:298–303. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vale W, Spiess J, Rivier C and Rivier J:
Characterization of a 41-residue ovine hypothalamic peptide that
stimulates secretion of corticotropin and beta-endorphin. Science.
213:1394–1397. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Vaughan J, Donaldson C, Bittencourt J, et
al: Urocortin, a mammalian neuropeptide related to fish urotensin I
and to corticotropin-releasing factor. Nature. 378:287–292. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bale TL and Vale WW: CRF and CRF
receptors: role in stress responsivity and other behaviors. Annu
Rev Pharmacol Toxicol. 44:525–557. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ataka K, Kuge T, Fujino K, Takahashi T and
Fujimiya M: Wood creosote prevents CRF-induced motility via 5-HT3
receptors in proximal and 5-HT4 receptors in distal colon in rats.
Auton Neurosci. 133:136–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Martinez V, Rivier J, Wang L and Tache Y:
Central injection of a new corticotropin-releasing factor (CRF)
antagonist, astressin, blocks CRF- and stress-related alterations
of gastric and colonic motor function. J Pharmacol Exp Ther.
280:754–760. 1997.
|
|
58
|
Tache Y, Martinez V, Million M and Wang L:
Stress and the gastrointestinal tract III. Stress-related
alterations of gut motor function: role of brain
corticotropin-releasing factor receptors. Am J Physiol Gastrointest
Liver Physiol. 280:G173–G177. 2001.PubMed/NCBI
|
|
59
|
O'Mahony SM, Marchesi JR, Scully P, et al:
Early life stress alters behavior, immunity, and microbiota in
rats: implications for irritable bowel syndrome and psychiatric
illnesses. Biol Psychiatry. 65:263–267. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Brevet M, Kojima H, Asakawa A, et al:
Chronic foot-shock stress potentiates the influx of bone
marrow-derived microglia into hippocampus. J Neurosci Res.
88:1890–1897. 2010.PubMed/NCBI
|
|
61
|
Sengupta JN: Visceral pain: the
neurophysiological mechanism. Handb Exp Pharmacol. 194:31–74. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Shindo T, Futagami S, Hiratsuka T, et al:
Comparison of gastric emptying and plasma ghrelin levels in
patients with functional dyspepsia and non-erosive reflux disease.
Digestion. 79:65–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lee KJ, Cha DY, Cheon SJ, Yeo M and Cho
SW: Plasma ghrelin levels and their relationship with gastric
emptying in patients with dysmotility-like functional dyspepsia.
Digestion. 80:58–63. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Sarnelli G, Caenepeel P, Geypens B,
Janssens J and Tack J: Symptoms associated with impaired gastric
emptying of solids and liquids in functional dyspepsia. Am J
Gastroenterol. 98:783–788. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Asakawa A, Inui A, Ueno N, Makino S,
Fujino MA and Kasuga M: Urocortin reduces food intake and gastric
emptying in lean and ob/ob obese mice. Gastroenterology.
116:1287–1292. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Fujino K, Inui A, Asakawa A, Kihara N,
Fujimura M and Fujimiya M: Ghrelin induces fasted motor activity of
the gastrointestinal tract in conscious fed rats. J Physiol.
550:227–240. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Fujimiya M, Itoh E, Kihara N, Yamamoto I,
Fujimura M and Inui A: Neuropeptide Y induces fasted pattern of
duodenal motility via Y(2) receptors in conscious fed rats. Am J
Physiol Gastrointest Liver Physiol. 278:G32–G38. 2000.PubMed/NCBI
|
|
68
|
Fujimiya M, Asakawa A, Ataka K, Kato I and
Inui A: Different effects of ghrelin, des-acyl ghrelin and
obestatin on gastroduodenal motility in conscious rats. World J
Gastroenterol. 14:6318–6326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Peeters TL: Central and peripheral
mechanisms by which ghrelin regulates gut motility. J Physiol
Pharmacol. 54(Suppl 4): S95–S103. 2003.PubMed/NCBI
|
|
70
|
Venkova K and Greenwood-Van Meerveld B:
Application of ghrelin to gastrointestinal diseases. Curr Opin
Investig Drugs. 9:1103–1107. 2008.PubMed/NCBI
|
|
71
|
Asakawa A, Inui A, Fujimiya M, et al:
Stomach regulates energy balance via acylated ghrelin and desacyl
ghrelin. Gut. 54:18–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ariyasu H, Takaya K, Iwakura H, et al:
Transgenic mice overexpressing des-acyl ghrelin show small
phenotype. Endocrinology. 146:355–364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chen CY, Chao Y, Chang FY, Chien EJ, Lee
SD and Doong ML: Intracisternal des-acyl ghrelin inhibits food
intake and non-nutrient gastric emptying in conscious rats. Int J
Mol Med. 16:695–699. 2005.PubMed/NCBI
|
|
74
|
Chen CY, Inui A, Asakawa A, et al:
Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted
stomach motility in conscious rats. Gastroenterology. 129:8–25.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Inhoff T, Monnikes H, Noetzel S, et al:
Desacyl ghrelin inhibits the orexigenic effect of peripherally
injected ghrelin in rats. Peptides. 29:2159–2168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Qader SS, Hakanson R, Rehfeld JF,
Lundquist I and Salehi A: Proghrelin-derived peptides influence the
secretion of insulin, glucagon, pancreatic polypeptide and
somatostatin: a study on isolated islets from mouse and rat
pancreas. Regul Pept. 146:230–237. 2008. View Article : Google Scholar
|
|
77
|
Banks WA, Tschop M, Robinson SM and Heiman
ML: Extent and direction of ghrelin transport across the
blood-brain barrier is determined by its unique primary structure.
J Pharmacol Exp Ther. 302:822–827. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Martinez V, Barquist E, Rivier J and Tache
Y: Central CRF inhibits gastric emptying of a nutrient solid meal
in rats: the role of CRF2 receptors. Am J Physiol. 274:G965–G970.
1998.PubMed/NCBI
|
|
79
|
Million M, Maillot C, Saunders P, Rivier
J, Vale W and Tache Y: Human urocortin II, a new CRF-related
peptide, displays selective CRF(2)-mediated action on gastric
transit in rats. Am J Physiol Gastrointest Liver Physiol.
282:G34–G40. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Kihara N, Fujimura M, Yamamoto I, Itoh E,
Inui A and Fujimiya M: Effects of central and peripheral urocortin
on fed and fasted gastroduodenal motor activity in conscious rats.
Am J Physiol Gastrointest Liver Physiol. 280:G406–G419.
2001.PubMed/NCBI
|
|
81
|
Zhang JV, Ren PG, Avsian-Kretchmer O, et
al: Obestatin, a peptide encoded by the ghrelin gene, opposes
ghrelin's effects on food intake. Science. 310:996–999. 2005.
View Article : Google Scholar
|
|
82
|
Chartrel N, Alvear-Perez R, Leprince J, et
al: Comment on ‘Obestatin, a peptide encoded by the ghrelin gene,
opposes ghrelin's effects on food intake’. Science.
315:7662007.
|
|
83
|
Holst B, Egerod KL, Schild E, et al: GPR39
signaling is stimulated by zinc ions but not by obestatin.
Endocrinology. 148:13–20. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Tremblay F, Perreault M, Klaman LD, Tobin
JF, Smith E and Gimeno RE: Normal food intake and body weight in
mice lacking the G protein-coupled receptor GPR39. Endocrinology.
148:501–506. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Bassil AK, Haglund Y, Brown J, et al:
Little or no ability of obestatin to interact with ghrelin or
modify motility in the rat gastrointestinal tract. Br J Pharmacol.
150:58–64. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Bresciani E, Rapetti D, Dona F, et al:
Obestatin inhibits feeding but does not modulate GH and
corticosterone secretion in the rat. J Endocrinol Invest.
29:RC16–RC18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Ataka K, Inui A, Asakawa A, Kato I and
Fujimiya M: Obestatin inhibits motor activity in the antrum and
duodenum in the fed state of conscious rats. Am J Physiol
Gastrointest Liver Physiol. 294:G1210–G1218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Takamori K, Mizuta Y, Takeshima F, et al:
Relation among plasma ghrelin level, gastric emptying, and
psychologic condition in patients with functional dyspepsia. J Clin
Gastroenterol. 41:477–483. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Nishizawa T, Suzuki H, Nomoto Y, et al:
Enhanced plasma ghrelin levels in patients with functional
dyspepsia. Aliment Pharmacol Ther. 24(Suppl 4): S104–S110. 2006.
View Article : Google Scholar
|
|
90
|
Shinomiya T, Fukunaga M, Akamizu T, et al:
Plasma acylated ghrelin levels correlate with subjective symptoms
of functional dyspepsia in female patients. Scand J Gastroenterol.
40:648–653. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Kim YS, Lee JS, Lee TH, et al: Plasma
levels of acylated ghrelin in patients with functional dyspepsia.
World J Gastroenterol. 18:2231–2237. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Taniguchi H, Ariga H, Zheng J, et al:
Endogenous ghrelin and 5-HT regulate interdigestive
gastrointestinal contractions in conscious rats. Am J Physiol
Gastrointest Liver Physiol. 295:G403–G411. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Tack J, Janssen P, Masaoka T, Farre R and
Van Oudenhove L: Efficacy of buspirone, a fundus-relaxing drug, in
patients with functional dyspepsia. Clin Gastroenterol Hepatol.
10:1239–1245. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Seto Y, Yoshida N and Kaneko H: Effects of
mosapride citrate, a 5-HT4-receptor agonist, on gastric
distension-induced visceromotor response in conscious rats. J
Pharmacol Sci. 116:47–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Lee JW, Sung KW, Lee OY, Lee SE and Sohn
CI: The effects of 5-HT4 receptor agonist, mosapride citrate, on
visceral hypersensitivity in a rat model. Dig Dis Sci.
57:1517–1524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Fujitsuka N, Asakawa A, Amitani H, Hattori
T and Inui A: Efficacy of ghrelin in cancer cachexia: clinical
trials and a novel treatment by rikkunshito. Crit Rev Oncog.
17:277–284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Arai M, Matsumura T, Tsuchiya N, et al:
Rikkunshito improves the symptoms in patients with functional
dyspepsia, accompanied by an increase in the level of plasma
ghrelin. Hepatogastroenterology. 59:62–66. 2012.PubMed/NCBI
|
|
98
|
Takeda H, Sadakane C, Hattori T, et al:
Rikkunshito, an herbal medicine, suppresses cisplatin-induced
anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology.
134:2004–2013. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Matsumura T, Arai M, Yonemitsu Y, et al:
The traditional Japanese medicine Rikkunshito increases the plasma
level of ghrelin in humans and mice. J Gastroenterol. 45:300–307.
2010. View Article : Google Scholar : PubMed/NCBI
|
